KORU Medical Systems to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024 Feb 21, 2024 7:00am EST
KORU Medical Systems to Participate in Piper Sandler’s 35th Annual Healthcare Conference Nov 29, 2023 7:00am EST
KORU Medical Systems, Inc. Announces Development Agreement for Next-generation Subcutaneous Immunoglobulin Infusion System Nov 08, 2023 4:10pm EST
KORU Medical Systems, Inc. Announces 2023 Third Quarter Financial Results and Updates Full Year 2023 Outlook Nov 08, 2023 4:05pm EST
KORU Medical Systems, Inc. Receives FDA 510(k) Clearance for FREEDOM60® Infusion System With Hizentra® 50 ML Prefilled Syringes Nov 07, 2023 4:05pm EST
KORU Medical Systems to Report Third Quarter Financial Results on November 8, 2023 Oct 25, 2023 4:05pm EDT
KORU Medical Systems to Present Two Abstracts at the Immunoglobulin National Society 2023 National Conference Oct 05, 2023 7:05am EDT
